Tulsa Pain Consultants, INC

Tulsa Pain Consultants, INC was paid $951K by Medicaid between Jan 2018 and Oct 2024, across 26 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.

33Billing provider infoTULSA PAIN CONSULTANTS, INC
TULSA, OK 74146

33aNPI1316074834assigned 02/28/2007

33bProvider typePain Clinic/Center

28Total paid$951K

24GClaims17,514

24DCodes billed26

24AFirst – last monthJan 2018 – Oct 2024

Compared with peers

Next to other Pain Clinic/Center providers in Oklahoma

Rank by total paid#2 of 5

Median peer was paid$320K

This provider vs. median3.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	5,741	$278K
2019	3,361	$141K
2020	2,750	$132K
2021	1,509	$72K
2022	2,028	$155K
2023	1,604	$120K
2024incomplete	521	$53K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	24%	7,064	7,007	$226K
64483		18%	1,304	1,304	$172K
64493		15%	1,302	1,269	$147K
64635		9.5%	343	343	$91K
64494		7.1%	1,149	1,113	$67K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	6.9%	1,187	1,182	$66K
64636		4.9%	304	292	$47K
64495		3.9%	754	723	$37K
99152		2.6%	974	965	$25K
01992		2.6%	1,419	1,388	$25K
62323		2.4%	191	191	$23K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	<1%	159	158	$8K

14 more codes

64490		<1%	59	$7K
64491		<1%	59	$3K
62321		<1%	24	$3K
99439		<1%	198	$1K
99490	Ccm add 20min	<1%	231	$1K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	12	$1K
99426		<1%	119	$804.60
77002		<1%	17	$438.19
64450		<1%	14	$317.95
80305		<1%	38	$300.19
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	15	$228.72
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	510	$143.17
99427		<1%	13	$78.41
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	55	$2.05

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialREVELIS, ANDREW (PRESIDENT)